Publication at Faculty of Medicine in Hradec Králové |
2010
Abstract
Committee of Society for metabolic skeletal diseases appends data about denosumab, zoledronic acid, and parathormone to complete guidelines for diagnosing and therapy of postmenopausal osteoporosis published previously.